文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

心脏骤停后保守与较高氧合目标:系统评价、Meta分析与试验序贯分析

Conservative Versus Higher Oxygen Targets Post-Cardiac Arrest: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
PubMed 文献 · Acad Emerg Med · 2026-01-01
一句话结论成人心脏骤停ROSC后,保守氧合较高氧合目标未改善全因死亡或神经结局,但增加低氧风险并改善无呼吸机天数。

保守氧合组全因死亡率(RR 0.96,95%CI 0.88-1.06)和不良神经结局(RR 0.96,95%CI 0.88-1.04)均无显著差异;多数亚组分析无显著差异,仅严格低温(33°C-34°C)亚组死亡率降低,但TSA显示证据不稳定。保守氧合增加低氧风险(RR 1.65),但改善无呼吸机天数(MD 2.14)。在当前正常体温(36°C-37.5°C)方案下,累积证据趋向于保守氧合无效,但确切信息量尚未完全累积。

要点

  • 成人心脏骤停ROSC后接受有创机械通气者,保守氧合较高氧合目标未显著改善全因死亡率(RR 0.96,95%CI 0.88-1.06)。
  • 保守氧合未显著改善不良神经结局(RR 0.96,95%CI 0.88-1.04),多数亚组分析无显著差异。
  • 仅严格低温(33°C-34°C)亚组显示死亡率降低,但试验序贯分析提示该证据不稳定。
  • 保守氧合增加低氧血症风险(RR 1.65),但改善无呼吸机天数(MD 2.14)。
  • 在当前正常体温(36°C-37.5°C)方案下,累积证据趋向于保守氧合策略无效,但确切信息量尚未完全累积。

适用人群与场景

  • 成人心脏骤停后恢复自主循环(ROSC)、接受有创机械通气的患者。
  • 纳入标准:仅限RCT,比较保守氧合与较高氧合对成人CA患者的影响。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及具体的氧合目标数值、药物剂量或给药方案。

红旗征与不能漏的情况

  • 保守氧合策略增加低氧血症风险(RR 1.65)。
  • 严格低温(33°C-34°C)亚组死亡率降低,但试验序贯分析提示证据不稳定。

研究设计与关键结果

  • 研究类型:系统评价、Meta分析与试验序贯分析,遵循PRISMA 2020方案,检索截至2026年6月。
  • 主要终点:保守氧合组全因死亡率无显著差异(RR 0.96,95%CI 0.88-1.06);不良神经结局无显著差异(RR 0.96,95%CI 0.88-1.04)。
  • 亚组分析:多数无显著差异,仅严格低温(33°C-34°C)亚组死亡率降低,但TSA显示证据不稳定。
  • 次要终点:无显著差异;保守氧合增加低氧血症风险(RR 1.65),改善无呼吸机天数(MD 2.14)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,仅纳入RCT。
  • 使用RoB 2评估偏倚风险,GRADE评估证据质量。
  • 局限性:原文未明确说明纳入RCT的偏倚风险等级或GRADE证据等级;TSA提示确切信息量尚未完全累积。

对床旁实践的改变

  • 在当前正常体温(36°C-37.5°C)方案下,保守氧合策略未显示改善全因死亡率或神经结局,趋向于无效。
  • 保守氧合可能增加低氧血症风险(RR 1.65),但可能改善无呼吸机天数(MD 2.14)。
  • 严格低温(33°C-34°C)亚组可能获益,但证据不稳定,需进一步验证。
  • 原文未提及适用与不适用人群的具体标准或常见陷阱。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Optimal oxygenation following return of spontaneous circulation (ROSC) remains uncertain, as both hypoxemia and hyperoxemia risk secondary injury. We conducted an updated systematic review and meta-analysis comparing the efficacy of restrictive versus higher oxygenation targets.

METHODS: A systematic review and meta-analysis following the PRISMA 2020 protocol was carried out from database inception through June 2026. Only RCTs examining the impact of restrictive oxygenation versus higher oxygenation for adult CA patients undergoing invasive mechanical ventilation were included. Risks of bias and the quality of the evidence were evaluated using RoB 2 and GRADE tools. A random-effects model was used for data synthesis and presented the results in RR/MD.

RESULTS: Eleven RCTs (12 reports) involving 4136 participants were included. Restrictive oxygenation showed no significant difference in all-cause mortality (RR 0.96, 95% CI 0.88-1.06) or unfavorable neurological outcomes (RR 0.96, 95% CI 0.88-1.04). Most subgroup analyses were non-significant, except for reduced mortality in the strict hypothermia subgroup (33°C-34°C), although TSA showed unstable evidence. No significant differences were observed in secondary outcomes. Restrictive oxygenation increased hypoxemia risk (RR 1.65) but improved ventilator-free days (MD 2.14).

CONCLUSION: There is no significant improvement in overall mortality, neurological outcome, or any other major clinical endpoint in adult CA patients with restrictive oxygen compared to higher oxygen therapy. Under current normothermia (36°C-37.5°C) protocols, the accumulated evidence trends toward futility for a restrictive approach, though the definitive information size has not yet been entirely accrued. Although restrictive levels could lead to an increased number of ventilator-free days, there will be an increased risk of hypoxemia.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Khan MM, Saboor A, Aqil M, et al. Conservative Versus Higher Oxygen Targets Post-Cardiac Arrest: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. Acad Emerg Med. 2026. PMID: 42872895. doi:10.1111/acem.70422

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。